Takeda Pharmaceutical Company Limited
Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

Abstract:

The present invention relates to a new and improved method for preparing a highly concentrated immunoglobulin composition from pooled plasma for subcutaneous injection. A composition comprising 20% or more immunoglobulin suitable for subcutaneous use is also described.